Dr. Dib is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
St Joseph Mercy Cancer Center
5301 East Huron River Drive, Suite 210
Ypsilanti, MI 48197Phone+1 734-712-1000Fax+1 734-712-1012- Is this information wrong?
Education & Training
- Johns Hopkins University Advanced Academic ProgramsMaster in Science, Individualized Genomics and Health, 2019 - 2022
- Harvard Medical SchoolPost-Graduate Program, Cancer Biology & Therapeutics: High Impact Cancer Research, 2018 - 2019
- University of RochesterFellowship, Hematology and Medical Oncology, 2003 - 2006
- Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2000 - 2003
- Lebanese University School of MedicineClass of 1999
Certifications & Licensure
- SD State Medical License Active through 2025
- NY State Medical License 2005 - 2025
- MI State Medical License 2014 - 2024
- MA State Medical License 2022 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer Start of enrollment: 2017 Jun 21
- Oxybutynin Chloride in Managing Hot Flashes Start of enrollment: 2016 Dec 09
- S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer Start of enrollment: 2017 Feb 24
- Join now to see all
Publications & Presentations
PubMed
- Granulomatous hepatitis: Is it bugs, drugs, or other untoward culprits?Neil Shah, Elie G Dib, Nora Joseph, Robert J Fontana> ;Clinical Liver Disease. 2024 Apr 15
- Regorafenib in Patients With Solid Tumors WithAlterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.Vaibhav Sahai, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vijay Suhag, Elie G Dib, Inderjit Mehmi, Kunal C Kadakia, Evan Pisick, Herbert L Duvivier, Phat Le...> ;JCO Precision Oncology. 2024 Apr 1
- 3 citationsPertuzumab Plus Trastuzumab in Patients With Lung Cancer WithMutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study.Apar K Ganti, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Elie G Dib, Herbert L Duvivier, Eugene R Ahn, Deepti Behl, Hossein Borghaei, Ani S Balmanoukian, An...> ;JCO Precision Oncology. 2023 Jun 1
- Join now to see all
Journal Articles
- Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamou...Steven F. Powell, Miroslaw Mazurczak, Elie G. Dib, Jonathon S. Bleeker, Louis H. Geeraerts, Matthew Tinguely, Michele M. Lohr, Steven C. McGraw, Ashley W. Jensen, Chri..., Investigational New Drugs, 3/21/2022
- Book review: Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and ManagementDib EG, Leukemia Research. 2004 Sept; 28 (9): 995
- Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational StudySteven F. Powell, Elie G. Dib, Jonathan S. Bleeker, Michael D. Keppen, Miroslaw Mazurczak, Keely M. Hack, Mark M. Gitau, Preston D. Steen, Shelby A. Terstriep, John Re..., JCO Precision Oncology, 2018
Abstracts/Posters
- Using bioinformatic tools to examine similarities between human PDL-1 protein and common tobacco (Nicotiana tabacum)Elie Dib, Nichiolas Hill, Jessica Wollard, Ji Woon Yoo, Joe Dib, Anutosh Ganguly, Clifford Cho, J Clin Oncol 38, 2020 (suppl 5; abstr 70). 2020 ASCO-SITC Clinical Immuno-Oncology Symposium. Poster Presentation
- Palbociclib (P) in patients (Pts) with non-small cell lung cancer (NSCLC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utilization Registry (...Eugene R Ahn, Pam K. Mangat, Elizabeth Garrett-Mayer, Susan Halabi, Elie G. Dib, Daniel Ernest Haggstrom, Kathryn B. Alguire, Ricardo H. Alvarez, Carmen Julia Calfa, T..., J Clin Oncol 37, 2019 (suppl; abstr 9041). 2019 ASCO Annual Meeting. Abstract Number: 9041
- Alliance A041702: A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (_ 70 Years...Elie G Dib, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Professional Memberships
- Member
- American Association of Cancer ResearchMember
- Society for Immunotherapy of Cancer (SITC)Member
- Fellow
- Member
Other Languages
- French
Hospital Affiliations
- Trinity Health Ann Arbor HospitalYpsilanti, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: